The U.S. Food and Drug Administration (FDA) is seeking public comment on a newly published discussion paper on the use of 3D-printed medical devices at the point of care.
In addition to providing background information on 3D printing, the paper provides potential point-of-care manufacturing scenarios and 16 questions for public comment, according to the FDA. The agency will use feedback on the paper to help guide future policy development.
The discussion paper can be found on the FDA's website. Comments will be open for 60 days here under Docket Number FDA-2021-N-1272.
